Primerica Reports Strong Q1 2026 Results with 18% EPS Growth and $135M Share Repurchases
summarizeSummary
Primerica reported strong Q1 2026 results with an 18% increase in diluted EPS, record ISP sales, and a significant $135 million in share repurchases, signaling robust financial health and shareholder returns.
check_boxKey Events
-
Strong Q1 2026 Financial Performance
Total revenues increased 8% to $872.7 million, net income rose 12% to $190.1 million, and diluted EPS grew 18% to $5.97 compared to Q1 2025.
-
Record Investment and Savings Products (ISP) Growth
ISP product sales reached a record $4.3 billion, up 22% year-over-year, with client asset values increasing 15% to $127 billion.
-
Significant Share Repurchases
The company repurchased $135 million of common stock during the quarter under its previously authorized $475 million share repurchase program.
-
Dividend Declared
A dividend of $1.20 per share was approved, payable on June 12, 2026.
auto_awesomeAnalysis
Primerica, Inc. delivered robust financial performance in the first quarter of 2026, with significant year-over-year increases across key metrics. Net earnings per diluted share surged by 18% to $5.97, driven by an 8% rise in total revenues and a 12% increase in net income. The Investment and Savings Products (ISP) segment was a primary growth driver, achieving record sales of $4.3 billion (up 22%) and a 15% increase in client asset values. While the life-licensed sales force and new life insurance policies issued saw declines, the Term Life business still generated a 1% increase in revenues and a 6% rise in pre-tax operating income. The company also executed a substantial share repurchase of $135 million during the quarter under its existing $475 million program, demonstrating a commitment to returning capital to shareholders. This strong operational and capital management performance provides a positive signal to investors.
At the time of this filing, PRI was trading at $280.00 on NYSE in the Finance sector, with a market capitalization of approximately $8.7B. The 52-week trading range was $230.09 to $288.03. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.